A case of periostitis secondary to voriconazole therapy in a heart transplant recipient

Clin Nucl Med. 2011 Mar;36(3):242-4. doi: 10.1097/RLU.0b013e31820902d8.

Abstract

A 66-year-old man with a history of heart transplant for idiopathic dilated cardiomyopathy presented with progressive bone pain and myalgias. He has been on voriconazole for a pulmonary Aspergillus infection for 9 months. He had an elevated alkaline phosphatase of 280. There is no history of rheumatologic disease. Drug-induced periostitis has recently been reported in patients on long-term voriconazole therapy after lung transplantation for prophylaxis and treatment of Aspergillus infection. This case demonstrates the same phenomenon in a heart transplant patient. This patient's symptoms improved after discontinuation of voriconazole.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antifungal Agents / adverse effects*
  • Heart Transplantation*
  • Humans
  • Male
  • Periostitis / chemically induced*
  • Periostitis / diagnostic imaging
  • Pyrimidines / adverse effects*
  • Tomography, Emission-Computed, Single-Photon
  • Tomography, X-Ray Computed
  • Triazoles / adverse effects*
  • Voriconazole
  • Whole Body Imaging

Substances

  • Antifungal Agents
  • Pyrimidines
  • Triazoles
  • Voriconazole